0001225208-11-011352.txt : 20110406
0001225208-11-011352.hdr.sgml : 20110406
20110406114447
ACCESSION NUMBER: 0001225208-11-011352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110404
FILED AS OF DATE: 20110406
DATE AS OF CHANGE: 20110406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canute Scott A
CENTRAL INDEX KEY: 0001303416
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14680
FILM NUMBER: 11742381
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENZYME CORP
CENTRAL INDEX KEY: 0000732485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061047163
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6172527500
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
X0303
4
2011-04-04
0000732485
GENZYME CORP
GENZ
0001303416
Canute Scott A
500 KENDALL STREET
CAMBRIDGE
MA
02142
1
Executive VP
Genzyme common stock (GENZ)
2011-04-04
4
M
0
25000.0000
0
A
25000.0000
D
Genzyme common stock (GENZ)
2011-04-04
4
D
0
25000.0000
74.0000
D
0.0000
D
Restricted Stock Units
2011-04-04
4
M
0
25000.0000
0.0000
D
2013-03-15
Genzyme common stock (GENZ)
25000.0000
0.0000
D
Stock Option (right to buy)
51.5200
2011-04-04
4
D
0
42750.0000
51.5200
D
2020-06-16
Genzyme common stock (GENZ)
42750.0000
0.0000
D
Stock Option (right to buy)
57.2200
2011-04-04
4
D
0
50000.0000
57.2200
D
2011-03-15
2020-03-15
Genzyme common stock (GENZ)
50000.0000
0.0000
D
The vested restricted stock units were scheduled to be released on 3/15/2013.
This option, which provided for vesting 20% at grant and 20% annually over four years, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.
Susan P. Cogswell, Attorney-in-Fact
2011-04-06